Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/112051
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDu, Y.en
dc.contributor.authorRayner, C.en
dc.contributor.authorJones, K.en
dc.contributor.authorTalley, N.en
dc.contributor.authorHorowitz, M.en
dc.date.issued2018en
dc.identifier.citationDiabetes Care, 2018; 41(3):627-637en
dc.identifier.issn0149-5992en
dc.identifier.issn1935-5548en
dc.identifier.urihttp://hdl.handle.net/2440/112051-
dc.description.abstract"If you haven't measured something, you really don't know much about it." -Karl Pearson (attributed). Gastrointestinal (GI) symptoms represent an important and often unappreciated cause of morbidity in diabetes, although the significance of this burden across the spectrum of patients and the underlying pathophysiology, including the relationship of symptoms with glycemic control, remain poorly defined. The relevance of GI symptoms and the necessity for their accurate assessment have increased with the greater focus on the gut as a therapeutic target for glucose lowering. This review addresses the prevalence, assessment, pathogenesis, and management of GI symptoms in diabetes, beginning with broad principles and then focusing on specific segments of the GI tract. We initially performed a literature search of PubMed by using synonyms and combinations of the following search terms: "gastrointestinal symptoms", "diabetes", "prevalence", "pathogenesis", "diagnosis", and "management". We restricted the search results to English only. Review papers and meta-analyses are presented as the highest level of evidence where possible followed by randomized controlled trials, uncontrolled trials, retrospective and observational data, and expert opinion.en
dc.description.statementofresponsibilityYang T. Du, Christopher K. Rayner, Karen L. Jones, Nicholas J. Talley and Michael Horowitzen
dc.language.isoenen
dc.publisherAmerican Diabetes Associationen
dc.rights© 2018 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.en
dc.subjectHumans; Gastrointestinal Diseases; Diabetes Mellitus; Prevalence; Disease Management; Randomized Controlled Trials as Topicen
dc.titleGastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and managementen
dc.typeJournal articleen
dc.identifier.rmid0030083363en
dc.identifier.doi10.2337/dc17-1536en
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/627011en
dc.identifier.pubid398861-
pubs.library.collectionMedicine publicationsen
pubs.library.teamDS14en
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidDu, Y. [0000-0002-1741-9866]en
dc.identifier.orcidRayner, C. [0000-0002-5527-256X]en
dc.identifier.orcidJones, K. [0000-0002-1155-5816]en
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]en
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.